Document is current
Any future updates will be listed below
-
Authors
Lagendijk, Tom https://orcid.org/0009-0008-1392-7397
Markwirth, Philipp
Schäfer, Ortwin
Tokcan, Mert
Böhm, Michael
Haring, Bernhard
-
Funding
Funding for this research was provided by:
Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
- License Information
-
More Information
Article History
Received: 2 March 2026
Accepted: 8 May 2026
First Online: 26 May 2026
Declarations
:
: Informed consent was obtained from all individual participants included in the study.
: Not applicable. The manuscript does not contain identifiable participant data or images.
: T.L. received speaker fees from Bristol-Myers-Squibb and Pfizer, none of which are related to the content of this manuscript.M.B. has received lecture fees from Abbott, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cytokinetics, Edwards, Medtronic, Novartis, ReCor, Servier, and Vifor. MB is a member of the advisory boards of Amgen, Bayer, Boehringer Ingelheim, Cytokinetics, Edwards, Medtronic, Novartis, Pfizer, ReCor, Servier, and Vifor, none of which are related to the content of this manuscript. He has received research funding from the German Research Foundation: DFG, SFB-TTR 219, S-01.B.H. received speaker fees from Bristol Myers Squibb, Boehringer Ingelheim, Pfizer none of which are related to the content of this manuscript.The remaining authors have nothing to disclose.
